BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Treatment
22 results:

  • 1. COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study.
    Tan WC; Tan JYJ; Lim JSJ; Tan RYC; Lee ARYB; Leong FL; Lee SC; Chai LYA; Tan TT; Malek MIBA; Ong B; Lye DC; Chiew CJ; Chng WJ; Lim ST; Bharwani LD; Tan IB; Sundar R; Tan KB
    JAMA Oncol; 2023 Sep; 9(9):1221-1229. PubMed ID: 37440245
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Use of Antibiotics During Immune Checkpoint Inhibitor treatment Is Associated with Lower Survival in Advanced Esophagogastric cancer.
    Zhang L; Kuang T; Chai D; Deng W; Wang P; Wang W
    Int Immunopharmacol; 2023 Jun; 119():110200. PubMed ID: 37099942
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sex-Specific Differences in the Risk of Heart Failure following Anti-HER2 Monoclonal Antibody Therapy.
    Suzuki Y; Kaneko H; Tamura Y; Okada A; Michihata N; Jo T; Takeda N; Morita H; Fujiu K; Node K; Yasunaga H; Komuro I
    Oncology; 2023; 101(6):358-361. PubMed ID: 36940681
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
    Liu Z; Liu H; Wang Y; Li Z
    BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Surgical and oncological outcomes of robotic- versus laparoscopic-assisted distal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a propensity score‑matched analysis of 1164 patients.
    Gao G; Liao H; Jiang Q; Liu D; Li T
    World J Surg Oncol; 2022 Sep; 20(1):315. PubMed ID: 36171631
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
    Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM
    Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prospective multicentre randomised clinical trial comparing survival rates, quality of life and nutritional status between advanced gastric cancer patients with different follow-up intensities: study protocol for the STOFOLUP trial.
    Eom BW; Koo DH; An JY; Lee HH; Kim HI; Hur H; Yoo MW; Ryu MH; Lee HJ; Kim SM; Park JH; Min JS; Seo KW; Jeong SH; Jeong O; Kwon OK; Ryu SW; Yoo CH; Bae JM; Ryu KW
    BMJ Open; 2021 Dec; 11(12):e056187. PubMed ID: 34880028
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. treatment Pattern for Advanced gastric cancer in Japan and Factors Associated with Sequential treatment: A Retrospective Administrative Claims Database Study.
    Komatsu Y; Hironaka S; Tanizawa Y; Cai Z; Piao Y; Boku N
    Adv Ther; 2022 Jan; 39(1):296-313. PubMed ID: 34716560
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care.
    Shimozaki K; Nakayama I; Takahari D; Kamiimabeppu D; Osumi H; Wakatsuki T; Ooki A; Ogura M; Shinozaki E; Chin K; Yamaguchi K
    ESMO Open; 2021 Oct; 6(5):100234. PubMed ID: 34461485
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction.
    Zhang F; Yin Y; Ni T; Zhang M; Zhou Z; Sun X; Kuang W; Li P
    Pharmazie; 2020 Aug; 75(8):389-394. PubMed ID: 32758339
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding.
    Lv Y; Wang Z; Li K; Wang Q; Bai W; Yuan X; Yu T; Niu J; Yang Z; Zhu X; Zhao J; Xue H; Jiang Z; Zhuge Y; Zhang C; Sun J; Ding P; Ren W; Li Y; Zhang K; Zhang W; Guo W; Luo B; Li X; Yuan J; Han N; Zhu Y; He C; Yin Z; Fan D; Han G
    Hepatology; 2021 Apr; 73(4):1478-1493. PubMed ID: 32706906
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
    Fujitani K; Nakamura K; Mizusawa J; Kuwata T; Shimoda T; Katayama H; Kushima R; Taniguchi H; Yoshikawa T; Boku N; Terashima M; Fukuda H; Sano T; Sasako M;
    Gastric Cancer; 2021 Jan; 24(1):197-204. PubMed ID: 32572792
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Family History of gastric cancer and
    Choi IJ; Kim CG; Lee JY; Kim YI; Kook MC; Park B; Joo J
    N Engl J Med; 2020 Jan; 382(5):427-436. PubMed ID: 31995688
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
    Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
    Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Cost-effectiveness and cost-benefit analysis of upper gastrointestinal cancer screening in Yangzhong City, Jiangsu Province, from 2009 to 2015].
    Feng X; Hua ZL; Qian DF; Zhou Q; Shi AW; Wei WW; Zhou JY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1115-1118. PubMed ID: 31683397
    [No Abstract]    [Full Text] [Related]  

  • 16. [Analysis of gastric gastrointestinal stromal tumors in Shandong Province: a midterm report of multicenter GISSG1201 study].
    Hou Q; Luo W; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Guo H; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1025-1030. PubMed ID: 28900994
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mortality differences by surgical volume among patients with stomach cancer: a threshold for a favorable volume-outcome relationship.
    Choi H; Yang SY; Cho HS; Kim W; Park EC; Han KT
    World J Surg Oncol; 2017 Jul; 15(1):134. PubMed ID: 28716145
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review.
    Serrano OK; Love C; Goldman I; Huang K; Ng N; Abraham T; Da Silva R; Friedmann P; Libutti SK; Kennedy TJ
    J Surg Oncol; 2016 May; 113(6):640-6. PubMed ID: 27115836
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
    Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
    Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma.
    Al-Batran SE; Van Cutsem E; Oh SC; Bodoky G; Shimada Y; Hironaka S; Sugimoto N; Lipatov ON; Kim TY; Cunningham D; Rougier P; Muro K; Liepa AM; Chandrawansa K; Emig M; Ohtsu A; Wilke H
    Ann Oncol; 2016 Apr; 27(4):673-9. PubMed ID: 26747859
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.